Daily Wear Central Corneal Swelling With Etafilcon A and 2 Silicone Hydrogel Materials
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 41
- 试验地点
- 1
- 主要终点
- Central Corneal Swelling
研究概览
简要总结
This is a prospective, single site, unmasked, cross-over study with three silicone hydrogel contact lenses comparing central corneal swelling.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •The participant must be at leat 18 years old or older and no greater than 65 years old. Children younger than18 will likely no be able to come back and forth to the clinic during the typical work week as outlined in the above (due to school schedules) and thus not be able to adhere to the protocol.
- •The participant must be a current soft contact lens wearer who routinely wears lenses at least 6-8 hours per day and at least 4 days per week for at least the past 3 months.
- •Refraction suitable for spherical soft contact lens powers between -1.00 and -6.00 D the participant must be correctable to 20/30 or better at distance with both eyes with dispensed contact lenses.
- •The participant must be free of any active anterior segment disorders that would preclude safe contact lens wear. Active anterior segment disorders and evidence of central microbial keratitis are not allowed. However, evidence of past CLPU will be allowed so long as no more than 3 such scars are detected bilaterally. Evidence of more than 3 CLPU-like scars places excessive risk on the participant for subsequent CIE.
- •The participant must be correctable to 20/25 or better in each eye with spectacles. Amblyopia will be excluded.
- •Flat and steep corneal curvatures from keratometry readings must be between 39.00 and 48.50 D, respectively. Corneal curvatures outside this range may be indicative of a disease state, and the participants are not expected to comfortably wear the study lenses.
- •The participant must own or agree to purchase a pair of spectacles that can be worn when lenses are removed, during the washout periods, or in case of ocular discomfort or emergency.
排除标准
- •The participant has worn rigid gas permeable contact lenses within the last 30 days or PMMA lenses within the past 12 months. These lenses can transiently alter the corneal shape and influence the fitting of soft contact lenses or alter endothelial cell morphology.
- •The participant has an immunocompromising disease or any other systemic disease that in the investigator's opinion will affect ocular health or increase risk during daily contact lens wear.
- •The participant is taking any medication that in the investigator's opinion will affect ocular physiology or study participation.
- •The participant has an ocular disease or condition such as aphakia, clinically significant corneal dystrophies, corneal edema, external ocular infection, iritis, or had any anterior segment surgery.
- •The participant is taking any ocular medications. If a participant was previous taking any ocular medications, the medications must have been discontinued at least 2 weeks prior to enrollment.
- •The participant must have less than or equal to grade 2 on any of the slit lamp observations of: upper tarsal papilla, corneal staining, corneal neovascularization, conjunctival injection, and lid erythema or scales.
- •The participant is currently pregnant or lactating. Participant who become pregnant during the study will be discontinued.
- •An employee or member of the UHCMC Eye Institute or a family member of any study personnel.
研究组 & 干预措施
etafilcon A/lotrafilcon B/comfilcon A
Subjects that were randomized to receive the etafilcon A lens 1st, the lotrafilcon B lens 2nd and the comfilcon A lens 3rd.
干预措施: comfilcon A (Device)
etafilcon A/lotrafilcon B/comfilcon A
Subjects that were randomized to receive the etafilcon A lens 1st, the lotrafilcon B lens 2nd and the comfilcon A lens 3rd.
干预措施: etafilcon A (Device)
etafilcon A/lotrafilcon B/comfilcon A
Subjects that were randomized to receive the etafilcon A lens 1st, the lotrafilcon B lens 2nd and the comfilcon A lens 3rd.
干预措施: lotrafilcon B (Device)
etafilcon A/comfilcon A/lotrafilcon B
Subjects that were randomized to receive the etafilcon A lens 1st, the comfilcon A lens 2nd and the lotrafilcon B lens 3rd.
干预措施: etafilcon A (Device)
etafilcon A/comfilcon A/lotrafilcon B
Subjects that were randomized to receive the etafilcon A lens 1st, the comfilcon A lens 2nd and the lotrafilcon B lens 3rd.
干预措施: lotrafilcon B (Device)
etafilcon A/comfilcon A/lotrafilcon B
Subjects that were randomized to receive the etafilcon A lens 1st, the comfilcon A lens 2nd and the lotrafilcon B lens 3rd.
干预措施: comfilcon A (Device)
comfilcon A/etafilcon A/lotrafilcon B
Subjects that were randomized to receive the comfilcon A lens 1st, the etafilcon A lens 2nd and the lotrafilcon B lens 3rd.
干预措施: comfilcon A (Device)
comfilcon A/etafilcon A/lotrafilcon B
Subjects that were randomized to receive the comfilcon A lens 1st, the etafilcon A lens 2nd and the lotrafilcon B lens 3rd.
干预措施: etafilcon A (Device)
comfilcon A/etafilcon A/lotrafilcon B
Subjects that were randomized to receive the comfilcon A lens 1st, the etafilcon A lens 2nd and the lotrafilcon B lens 3rd.
干预措施: lotrafilcon B (Device)
comfilcon A/lotrafilcon B/etafilcon A
Subjects that were randomized to receive the comfilcon A lens 1st, the lotrafilcon B lens 2nd and the etafilcon A lens 3rd.
干预措施: etafilcon A (Device)
comfilcon A/lotrafilcon B/etafilcon A
Subjects that were randomized to receive the comfilcon A lens 1st, the lotrafilcon B lens 2nd and the etafilcon A lens 3rd.
干预措施: lotrafilcon B (Device)
comfilcon A/lotrafilcon B/etafilcon A
Subjects that were randomized to receive the comfilcon A lens 1st, the lotrafilcon B lens 2nd and the etafilcon A lens 3rd.
干预措施: comfilcon A (Device)
lotrafilcon B/etafilcon A/comfilcon A
Subjects that were randomized to receive the lotrafilcon B lens 1st, the etafilcon A lens 2nd and the comfilcon A lens 3rd.
干预措施: comfilcon A (Device)
lotrafilcon B/etafilcon A/comfilcon A
Subjects that were randomized to receive the lotrafilcon B lens 1st, the etafilcon A lens 2nd and the comfilcon A lens 3rd.
干预措施: etafilcon A (Device)
lotrafilcon B/etafilcon A/comfilcon A
Subjects that were randomized to receive the lotrafilcon B lens 1st, the etafilcon A lens 2nd and the comfilcon A lens 3rd.
干预措施: lotrafilcon B (Device)
lotrafilcon B/comfilcon A/etafilcon A
Subjects that were randomized to receive the lotrafilcon B lens 1st, the comfilcon A lens 2nd and the etafilcon A lens 3rd.
干预措施: etafilcon A (Device)
lotrafilcon B/comfilcon A/etafilcon A
Subjects that were randomized to receive the lotrafilcon B lens 1st, the comfilcon A lens 2nd and the etafilcon A lens 3rd.
干预措施: lotrafilcon B (Device)
lotrafilcon B/comfilcon A/etafilcon A
Subjects that were randomized to receive the lotrafilcon B lens 1st, the comfilcon A lens 2nd and the etafilcon A lens 3rd.
干预措施: comfilcon A (Device)
结局指标
主要结局
Central Corneal Swelling
时间窗: 6-8 Hours Post lens insertion
Corneal swelling measurements were taken in the right eye during slit lamp evaluations, 6-8 hours post lens insertion. The average corneal swelling per lens was reported.
次要结局
- Limbal Redness(6-8 hours post lens insertion)